Browsing Tag
FebriDx
3 posts
Lumos Diagnostics Holdings Limited puts FebriDx US rollout at centre of ASX:LDX rerating test
Find out how Lumos Diagnostics Holdings is using FebriDx US adoption to test whether ASX:LDX can turn regulatory wins into revenue.
Lumos Diagnostics (ASX: LDX) wins full U.S. Medicare reimbursement for FebriDx
Lumos Diagnostics secures full Medicare MAC reimbursement for FebriDx, opening doors to U.S. healthcare adoption. Find out what’s next for LDX shares.
Lumos Diagnostics (ASX: LDX) reaches 500-patient milestone in FebriDx CLIA study
Lumos Diagnostics hits a key 500-patient milestone in its FebriDx CLIA waiver study, triggering BARDA funds. FDA application expected by October 2025.